Randomised, Double-blind, Phase II Evaluation of the Safety and Immunogenicity Following Administration of Live Attenuated JE Vaccine (ChimeriVax-JE) and Yellow Fever Vaccine (STAMARIL).

Trial Profile

Randomised, Double-blind, Phase II Evaluation of the Safety and Immunogenicity Following Administration of Live Attenuated JE Vaccine (ChimeriVax-JE) and Yellow Fever Vaccine (STAMARIL).

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Jan 2014

At a glance

  • Drugs Japanese encephalitis vaccine (Primary) ; Yellow fever vaccine
  • Indications Japanese encephalitis; Yellow fever
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Sanofi
  • Most Recent Events

    • 29 Sep 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top